Literature DB >> 15557288

Heterogeneity of the neuropeptide Y (NPY) contractile and relaxing receptors in horse penile small arteries.

Dolores Prieto1, Luis Rivera de Los Arcos, Pilar Martínez, Sara Benedito, Albino García-Sacristán, Medardo Hernández.   

Abstract

The distribution of neuropeptide Y (NPY)-immunorective nerves and the receptors involved in the effects of NPY upon electrical field stimulation (EFS)- and noradrenaline (NA)-elicited contractions were investigated in horse penile small arteries. NPY-immunoreactive nerves were widely distributed in the erectile tissues with a particularly high density around penile intracavernous small arteries. In small arteries isolated from the proximal part of the corpora cavernosa, NPY (30 nM) produced a variable modest enhancement of the contractions elicited by both EFS and NA. At the same concentration, the NPY Y(1) receptor agonist, [Leu(31), Pro(34)]NPY, markedly potentiated responses to EFS and NA, whereas the NPY Y(2) receptor agonist, NPY(13-36), enhanced exogenous NA-induced contractions. In arteries precontracted with NA, NPY, peptide YY (PYY), [Leu(31), Pro(34)]NPY and the NPY Y(2) receptor agonists, N-acetyl[Leu(28,31)]NPY (24-36) and NPY(13-36), elicited concentration-dependent contractile responses. Human pancreatic polypeptide (hPP) evoked a biphasic response consisting of a relaxation followed by contraction. NPY(3-36), the compound 1229U91 (Ile-Glu-Pro-Dapa-Tyr-Arg-Leu-Arg-Tyr-NH2, cyclic(2,4')diamide) and eventually NPY(13-36) relaxed penile small arteries. The selective NPY Y(1) receptor antagonist BIBP3226 ((R)-N(2)-(diphenacetyl)-N-[(4-hydroxyphenyl)methyl]D-arginineamide) (0.3 microM) shifted to the right the concentration-response curves to both NPY and [Leu(31), Pro(34)]NPY and inhibited the contractions induced by the highest concentrations of hPP but not the relaxations observed at lower doses. In the presence of the selective NPY Y(2) receptor antagonist BIIE0246 ((S)-N2-[[1-[2-[4-[(R,S)-5,11-dihydro-6(6h)-oxodibenz[b,e]azepin-11-y1]-1-piperazinyl]-2-oxoethyl]cyclo-pentyl-N-[2-[1,2-dihydro-3,5 (4H)-dioxo-1,2-diphenyl-3H-1,2, 4-triazol-4-yl]ethyl]-argininamide) (0.3 microM), the Y(2) receptor agonists NPY(13-36) and N-acetyl[Leu(28,31)]NPY (24-36) evoked potent slow relaxations in NA-precontracted arteries, under conditions of nitric oxide (NO) synthase blockade. Mechanical removal of the endothelium markedly enhanced contractions of NPY on NA-precontracted arteries, whereas blockade of the neuronal voltage-dependent Ca(2+) channels did not alter NPY responses. These results demonstrate that NPY can elicit dual contractile/relaxing responses in penile small arteries through a heterogeneous population of postjunctional NPY receptors. Potentiation of the contractions evoked by NA involve both NPY Y(1) and NPY Y(2) receptors. An NO-independent relaxation probably mediated by an atypical endothelial NPY receptor is also shown and unmasked in the presence of selective antagonists of the NPY contractile receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557288      PMCID: PMC1575958          DOI: 10.1038/sj.bjp.0706005

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

1.  BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist.

Authors:  H Doods; W Gaida; H A Wieland; H Dollinger; G Schnorrenberg; F Esser; W Engel; W Eberlein; K Rudolf
Journal:  Eur J Pharmacol       Date:  1999-11-19       Impact factor: 4.432

2.  Neuropeptide Y regulates intracellular calcium through different signalling pathways linked to a Y(1)-receptor in rat mesenteric small arteries.

Authors:  D Prieto; C L Buus; M J Mulvany; H Nilsson
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

3.  Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivo.

Authors:  R E Malmström
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

4.  Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries.

Authors:  J You; L Edvinsson; R M Bryan
Journal:  J Cereb Blood Flow Metab       Date:  2001-01       Impact factor: 6.200

5.  Food intake inhibition and reduction in body weight gain in lean and obese rodents treated with GW438014A, a potent and selective NPY-Y5 receptor antagonist.

Authors:  A J Daniels; M K Grizzle; R P Wiard; J E Matthews; D Heyer
Journal:  Regul Pept       Date:  2002-06-15

6.  Autoinhibitory function of the sympathetic prejunctional neuropeptide Y Y(2) receptor evidenced by BIIE0246.

Authors:  Rickard E Malmström; Jon O N Lundberg; Eddie Weitzberg
Journal:  Eur J Pharmacol       Date:  2002-03-29       Impact factor: 4.432

7.  Characterization of NPY receptors mediating contraction in rat intramyocardial coronary arteries.

Authors:  D Prieto; A García-Sacristán; U Simonsen
Journal:  Regul Pept       Date:  1998-09-25

Review 8.  Penile arteries and erection.

Authors:  Ulf Simonsen; Albino García-Sacristán; Dolores Prieto
Journal:  J Vasc Res       Date:  2002 Jul-Aug       Impact factor: 1.934

9.  Involvement of peripheral neuropeptide Y receptors in sympathetic modulation of acute cutaneous flare induced by intradermal capsaicin.

Authors:  Q Lin; X Zou; Y Ren; J Wang; L Fang; W D Willis
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

10.  Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats.

Authors:  Kathryn A Gradin; Jia-Yi Li; Ove Andersson; Ulf Simonsen
Journal:  J Vasc Res       Date:  2003 May-Jun       Impact factor: 1.934

View more
  2 in total

1.  Anatomical, immnunohistochemical and physiological characteristics of the vomeronasal vessels in cows and their possible role in vomeronasal reception.

Authors:  Ignacio Salazar; Pablo Sánchez-Quinteiro; Nuria Alemañ; Dolores Prieto
Journal:  J Anat       Date:  2008-05       Impact factor: 2.610

2.  Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats.

Authors:  Kathryn A Gradin; Carsten L Buus; Jia-Yi Li; Ole Frøbert; Ulf Simonsen
Journal:  Br J Pharmacol       Date:  2006-05-22       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.